Cialis Users Told to Monitor Eye Health After Glaucoma Study; Men Weigh the Trade-Off

LONDON — Men have long been told they cannot have everything, and science has once again confirmed it. A new study published in the British Journal of Ophthalmology, which followed 74,000 men, found that those who take tadalafil — sold as Cialis — long term are significantly more likely to develop glaucoma, a serious eye condition that can lead to blindness. Researchers now recommend baseline eye examinations and ongoing monitoring for long-term users, particularly those with existing risk factors.

The study’s findings, reported by BMJ Group and covered by The Independent, prompted the headline that every man taking the drug immediately dreaded: the pill that helps you see clearly in one department may be clouding the windows of the other.

Let’s be clear about what the researchers are asking. They are not saying men should stop taking the medication. They are saying men should keep an eye on their eyes — while presumably continuing to appreciate the drug’s other documented benefits. It is, in the truest sense, a trade-off. The human body, it turns out, is a limited-resource environment, and men are now being asked to choose which senses they would like to retain.

“I’ve been prescribing this medication for 15 years, and my patients have never once asked me about their intraocular pressure,” said Dr. Harold Pickering, a urologist who spoke to the Freedom Eagle on condition that we not ask him about his own prescription. “Now every one of them is going to want a glaucoma screening, and I’m going to have to refer them to the ophthalmologist down the hall, who is going to have to explain to a grown man that his eyes are fine, it’s just the rest of him that’s in trouble. This is going to double my paperwork.”

The study notes that tadalafil is also prescribed for enlarged prostate symptoms, which means a significant portion of long-term users are men who simply wanted to urinate with confidence and are now being told to monitor their optic nerves. Life, as ever, giveth and taketh away.

Patient groups have responded with characteristic grace. “I’ll take the eye monitoring,” said Raymond Gable, 67, of Leeds, who has used the medication for six years. “You only get one pair of eyes. Well — you only get one of everything, really. That’s the problem. It’s a body, not a subscription service.”

Researchers stress the findings “do not contraindicate tadalafil use” and that the absolute risk remains modest for most men. But they recommend that patients with a family history of glaucoma or elevated eye pressure get a baseline eye exam, and that long-term users schedule regular monitoring. In other words: enjoy the view, but check the windows.

At press time, men across the country were reportedly squinting at eye charts, wondering whether they had always been that blurry, and silently calculating which organ they could afford to lose.